RUA Life Sciences plc (FRA:AOHA)

Market Cap	12.70M +57.0%
Revenue (ttm)	5.11M +74.5%
Net Income	-166.50K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1710
Previous Close	0.1710
Day's Range	0.1710 - 0.1710
52-Week Range	0.0815 - 0.1900
Beta	n/a
RSI	76.52
Earnings Date	Jun 25, 2026

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also enga...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1996
• Employees: 59
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AOHA

Financial Performance

Financial numbers in GBP